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Host-Nonspecific Iron Acquisition Systems and Virulence in the
Zoonotic Serovar of Vibrio vulnificus
David Pajuelo,a Chung-Te Lee,b Francisco J. Roig,a Manuel L. Lemos,c Lien-I Hor,b,d Carmen Amaroa
Department of Microbiology and Ecology, University of Valencia, Valencia, Spaina; Institute of Basic Medical Sciences and Department of Microbiology and Immunology,
National Cheng-Kung University, Tainan, Taiwan, Republic of Chinab; Department of Microbiology and Parasitology, Institute of Aquaculture and Faculty of Biology,
University of Santiago de Compostela, Santiago de Compostela, Galicia, Spainc; College of Medicine, National Cheng-Kung University, Tainan, Taiwan, Republic of Chinad
The zoonotic serovar of Vibrio vulnificus (known as biotype 2 serovar E) is the etiological agent of human and fish vibriosis. The
aim of the present work was to discover the role of the vulnibactin- and hemin-dependent iron acquisition systems in the patho-
genicity of this zoonotic serovar under the hypothesis that both are host-nonspecific virulence factors. To this end, we selected
three genes for three outer membrane receptors (vuuA, a receptor for ferric vulnibactin, and hupA and hutR, two hemin recep-
tors), obtained single and multiple mutants as well as complemented strains, and tested them in a series of in vitro and in vivo
assays, using eels andmice as animal models. The overall results confirm that hupA and vuuA, but not hutR, are host-nonspecific
virulence genes and suggest that a third undescribed host-specific plasmid-encoded system could also be used by the zoonotic
serovar in fish. hupA and vuuA were expressed in the internal organs of the animals in the first 24 h of infection, suggesting that
they may be needed to achieve the population size required to trigger fatal septicemia. vuuA and hupA were sequenced in strains
representative of the genetic diversity of this species, and their phylogenies were reconstructed by multilocus sequence analysis
of selected housekeeping and virulence genes as a reference. Given the overall results, we suggest that both genes might form part
of the core genes essential not only for disease development but also for the survival of this species in its natural reservoir, the
aquatic environment.
Vibrio vulnificus is a native member of the microbiota of tem-perate and tropical marine ecosystems (1–5). The species is a
human pathogen that causes different pathologies depending on
the route of entry into the body (skin contact or injuries versus
ingestion of raw seafood) and patient immune status (compro-
mised versus noncompromised) (3, 6–10). The most severe pa-
thology caused by V. vulnificus is sepsis in immunocompromised
patients, either after raw seafood ingestion (primary) or after
wound infection (secondary) (8, 10, 11). The mortality rate for
these sepsis cases may exceed 50% (11). Interestingly, V. vulnificus
also causes “warm-water vibriosis” in different species of aquatic
animals, especially under farmed conditions (12). The most sus-
ceptible host for this vibriosis is the eel (Anguilla anguilla and A.
japonica) (12). Warm-water vibriosis in its acute form is a primary
sepsis, but in this case, it is triggered irrespective of the pathogen’s
route of entry (gills, intestine, or skin injury, etc.) and/or the host’s
immune status (13).
The species V. vulnificus is subdivided into three biotypes,
among which biotype 2 (Bt2) includes the fish-virulent strains
(14, 15). Recent phylogenetic studies suggest that Bt2 is a
polyphyletic group, which has probably emerged in the fish-farm-
ing environment from commensal strains by the acquisition of a
virulence plasmid (pVvBt2) that encodes resistance to the innate
immune system of eels (and probably other teleosts) (16–19). This
biotype includes a zoonotic clonal complex, designated serovar E
(SerE) (17, 20, 21). Thus, V. vulnificus Bt2-SerE is the most suit-
able candidate to perform comparative fish-versus-mammal vir-
ulence studies.
Nutritional immunity, the most ancient system of defense
against pathogens common to all vertebrates (22), consists of met-
abolic adjustments in order to make iron unavailable to microor-
ganisms. To overcome iron starvation in host tissues, V. vulnificus
Bt1 produces two siderophores: vulnibactin (a catechol) and an
unnamed hydroxamate siderophore (23, 24). Bt1 strains use vul-
nibactin for scavenging iron from human transferrin (Tf) both in
vitro and in vivo (in mice, the animal model for human vibriosis).
Thus, Bt1 mutants deficient in vulnibactin production or in the
vulnibactin receptor (VuuA) grow less efficiently in iron-deficient
media and are attenuated in mouse virulence (25–27). In addition,
V. vulnificus Bt1 can utilize non-Tf-bound iron through a heme
receptor, HupA, also involved in virulence for mice (28, 29). Re-
cently, a novel heme-specific receptor without any known role in
virulence, HutR, was described in V. vulnificus Bt1 (30). V. vulni-
ficus Bt2 seems to produce phenolates and hydroxamates and uses
hemin (Hm) as the sole iron source (31, 32). The chemical nature
of the siderophores as well as the role of iron acquisition systems in
virulence of the zoonotic variant are unknown.
The present study is focused on the host-nonspecific iron ac-
quisition systems used by the zoonotic serovar to infect both hu-
mans and fish. These systems are usually under Fur (ferric uptake
regulator) control. Since the genome of Bt2 has not been se-
quenced, we identified the iron uptake genes by using a Fur titra-
tion assay (FURTA) (enables the identification of Fur-regulated
genes) (33), and subsequently, we obtained single and multiple
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mutants by allelic exchange in selected genes of strain CECT4999.
The mutants and the wild-type strain were used in a series of in
vitro and in vivo tests, including virulence in eels and mice, animal
models for fish and human vibriosis, respectively. Finally, the evo-
lutionary history of the identified virulence genes was inferred and
compared with that of the species by multilocus sequence analysis
(MLSA).
MATERIALS AND METHODS
Strains and general culture conditions. Bacterial strains (Table 1) were
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Descriptiond Isolation source or reference
Strains
V. vulnificus
529T Biotype 1 Human blood (USA)a,b
YJ016 Biotype 1 Human blood (Taiwan)c
CS9133 Biotype 1 Human blood (South Korea)b
B2 Biotype 1 Human blood (China)b
MO6-24/O Biotype 1 Diseased human (USA)b
CMCP6 Biotype 1 Diseased human (South Korea)b
94-8-119 Biotype 1 Human wound (Denmark)b
E64MW Biotype 1 Human wound (USA)b
CG100 Biotype 1 Oyster (Taiwan)b
JY1305 Biotype 1 Oyster (USA)b
JY1701 Biotype 1 Oyster (USA)b
CECT4608 Biotype 1 Healthy eel (Spain)b
CECT4866 Biotype 2 serovar E Human blood (Australia)b
CIP8190 Biotype 2 serovar E Human blood (France)b
94-8-112 Biotype 2 serovar E Human wound (Denmark)b
CECT5763 Biotype 2 serovar E Eel tank water (Spain)b
CECT4604 Biotype 2 serovar E Diseased eel (Spain)b
CECT4999 Biotype 2 serovar E Diseased eel (Spain)b
CECT5198 Biotype 2 serovar A Diseased eel (Spain)b
CECT5768 Biotype 2 serovar A Diseased eel (Spain)b
CECT5769 Biotype 2 serovar A Diseased eel (Spain)b
A11 Biotype 2 serovar A Diseased eel (Spain)b
A13 Biotype 2 serovar A Diseased eel (Spain)b
95-8-7 Biotype 2 serovar I Diseased eel (Denmark)b
95-8-6 Biotype 2 serovar I Diseased eel (Denmark)b
95-8-161 Biotype 2 serovar I Diseased eel (Denmark)b
95-8-162 Biotype 2 serovar I Diseased eel (Denmark)b
11028 Biotype 3 Human blood (Israel)b
12 Biotype 3 Human blood (Israel)b
hupA CECT4999 hupA-defective mutant This study
vuuA CECT4999 vuuA-defective mutant This study
hutR CECT4999 hutR-defective mutant This study
hupA vuuA CECT4999 hupA vuuA-defective double mutant This study
hupA hutR CECT4999 hupA hutR-defective double mutant This study
chupA hupA complemented strain This study
cvuuA vuuA complemented strain This study
E. coli
DH5 Cloning strain Invitrogen
H1717 araD139 lacU169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR aroB fhuF- placMu 74
S17-1pir Strain containing plasmid pCVD442; thi pro hsdR hsdM recA::RP4-2-Tc::Mu pir Kmr Nalr 75
Plasmids
pUC18 Cloning vector; Ampr Fermentas
pCVD442 Suicide vector; sacB bla mobRP4 R6k ori 43
pGemT-easy T/A cloning vector; Ampr Promega
phupA pCVD442 with hupA in the MCS This study
pvuuA pCVD442 with vuuA in the MCS This study
phutR pCVD442 with hutR in the MCS This study
a Type strain of the species.
b Strains whose published sequences were used for the phylogenetic analysis (sequences for vvha, rtxA1, wzz, pilF, glp, mdh, pyrC, and pntA were taken from references 17 and 52–
56).
c Strain used as a reference for primer design for the vuuA, hupA, and hutR genes.
d MCS, multiple-cloning site.
Pajuelo et al.
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routinely grown in LB-1 (Luria-Bertani broth plus 1% NaCl)/LBA-1
(Luria-Bertani agar plus 1% NaCl) or in CM9 (M9 minimal medium [34]
supplemented with 0.2% Casamino Acids [Difco])/CM9A (CM9 agar) at
28°C (V. vulnificus Bt2-SerE) or 37°C (Escherichia coli) and were stored in
LB-1 plus glycerol (17%) at80°C. For FURTA (see below), the bacterial
strains were grown on MacConkey agar base (Difco) supplemented with
1% lactose and 0.04 mM FeSO4 (MFe). If necessary, ampicillin (100
g/ml) or polymyxin B (50 U/ml) was added to the medium.
Growth in fresh blood or plasma and in artificial media supple-
mentedwithdifferent iron sources.Fresh blood (extracted with a syringe
treated with heparin [50 mg/ml in a 0.9% NaCl solution]), erythrocytes
(5% [vol/vol] in PBS-1 [phosphate-buffered saline–1% NaCl, pH 7.0]),
and plasma (obtained from eel and/or human blood according to meth-
ods described previously [35, 36]) were added to CM9 in a 1:1 proportion
as supplements for bacterial growth. Bacteria the were grown in CM9-HP
(human plasma), CM9-EP (eel plasma), CM9-HP-Fe20/200 (CM9-HP
plus 20 or 200  FeCl3), CM9-EP-Fe20/200 (CM9-EP plus 20 or 200
 FeCl3), and CM9-EE [1% eel erythrocytes plus 100  ethylenedi-
amine-di-(o-hydroxyphenylacetic) acid (EDDA; Sigma)]. Bacteria were
also grown in CM9-Fe (CM9 plus 100  FeCl3), CM9-Hm-0.1/10 (0.1
or 10 bovine Hm [Sigma] plus 100 EDDA [Sigma]), CM9-Hb-10
(10  bovine hemoglobin [Sigma] plus 100  EDDA [Sigma]), and
CM9-Tf (40  iron-free human apotransferrin [Sigma]).
Fresh blood and plasma as well as inactivated plasma (plasma heated at
56°C for 30 min [37] or supplemented with 100M FeCl3 [37]) were also
distributed into 96-well microtiter plates at a ratio of 100 l per well,
and100 l of a bacterial suspension in PBS-1 containing 103 CFU/ml was
then added to each well. The plates were incubated at 28°C (eel) or 37°C
(human) with shaking (200 rpm) for 24 h. Bacterial counts on plates of
tryptone soy agar plus 1% NaCl (TSA-1) were performed by the drop plate
method at 0, 4, and 24 h of incubation.
Siderophore detection. The chrome azurol S (CAS) assay was used to
detect siderophore production in the supernatant of iron-restricted cul-
tures (38). The Arnow phenolic acid assay and the Csàky hydroxylamine
hydroxamic acid assay were carried out to detect phenolic- and hy-
droxamic-type siderophores, respectively, as previously described (39,
40). Vibrio anguillarum strain RV22 and Photobacterium damselae subsp.
damselae strain CECT626T were used as positive controls for the Arnow
and Csàky tests, respectively (31).
Fur titration assay. The Fur titration assay (FURTA) is based on mul-
tiple plasmid-encoded Fur boxes derepressing chromosomal Fur-regu-
lated genes by titrating the Fur protein (33). FURTA was performed ac-
cording to methods described previously (33). Total DNA from V.
vulnificus strain CECT4999 was extracted and partially digested by using
the frequent-cut restriction enzyme Sau3AI, and the 0.5- to 6-kb frag-
ments were cloned into the BamHI site of pT7-7 and transformed into E.
coliDH5 (Table 1). DNA from a pool of 5,000 colonies was extracted and
transformed by electroporation in E. coli H1717 on MFe, where Fur-
regulated promoters were identified as red transformants.
Isolation of mutant and complemented strains. The general proce-
dures for DNA extraction and manipulation were performed according
methods described previously (41). Single and multiple in-frame mutants
were obtained by allelic exchange (42). Briefly, a series of plasmids was
created in pCVD442 (a suicide vector that allows negative selection by
sucrose) (43) by cloning fragments that contained the upstream and
downstream regions of each gene with an in-frame deletion of the major
part of the coding sequence (Table 1). Plasmids phupA, pvuuA, and
phutR, containing the up- and downstream regions of hupA, vuuA, and
hutR, respectively, were transferred by conjugation from E. coli S17-1pir
into wild-type strain CECT4999 to obtain single mutants. To obtain dou-
ble mutants, the corresponding plasmids were transferred by conjugation
into the corresponding single mutants (Table 1). Transconjugants were
subsequently selected with 10% sucrose from those having lost pCVD442
via a second homologous recombination event. Complemented chupA
and cvuuA strains were generated by conjugal transfer of the wild-type
genes, obtained with primer pair hupA-cF/hupA-cR or vuuA-cF/vuuA-cR,
cloned into pGEMT (19) (Table 1). Table 2 shows all the primers, which
were designed from the published genome sequences of V. vulnificus
strain YJ016.
In vitro characterization of mutants. (i) Tf bioassay. The ability to
use iron from iron-saturated human Tf (holo-Tf; Sigma) was assayed by
measuring the growth halo around Tf discs (soaked in a solution of 1 mM
holo-Tf) placed onto CM9A-E (CM9 –100 M EDDA) plates previously
inoculated with 100 l of a culture grown overnight in CM9.
(ii) Hm bioassay. The ability to use Hm as the sole iron source was
tested by measuring bacterial growth (optical density at 600 nm [OD600])
in CM9-Hm-1 at 1-h intervals during 10 h, with a final measurement at 24
h (32). Tubes were inoculated with a culture grown overnight in CM9
(1/100, vol/vol) and were incubated at 28°C with shaking (200 rpm).
(iii) Outer membrane protein analysis. Strains were grown in
CM9-Fe and CM9-Tf for 12 h, and outer membrane proteins (OMPs)
were extracted as described previously (44). OMP samples were fraction-
ated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) according to the method of Laemmli (45), using a separation gel of
10% acrylamide. The protein bands were stained with Coomassie brilliant
blue.
In vivo phenotypic characterization of mutants. All the protocols
were reviewed and approved by the Animal Ethic Committee of the Uni-
versity of Valencia.
(i) Animal maintenance. Three populations of farmed European eel
(Anguilla anguilla) of 10 g, 20 g, and 100 g were used for virulence assays,
colonization assays, and blood extraction, respectively. The eels were pur-
chased from a local eel farm that does not vaccinate against V. vulnificus.
Fish were placed in quarantine into 170-liter tanks (6 fish of 100 g, 12 of 20
g, or 20 of 10 g per tank) containing brackish water (1.5% NaCl, pH 7.6)
with aeration, filtration, and feeding systems at 25°C for a week. After
quarantine, healthy fish were distributed into 100-liter tanks at the same
ratio, infected withV. vulnificus (13), and maintained for 1 week under the
same maintenance conditions but without feeding. Six- to eight-week-old
BALB/c mice were purchased from Harlan Laboratory Models S.L. and
maintained for 48 h in 100-liter plastic cages with water and feed supplied
by the animal housing facilities of the University of Valencia.
(ii) Virulence. For eels, virulence was determined after immersion or
intraperitoneal (i.p.) injection according to methods described previously
(13). Mice were preinjected with iron (Hm [2.8 g/g of mouse], FeCl3 [9
g/g of mouse], or Hm plus FeCl3 [1.4 g of Hm/g of mouse plus 4.5 g
of FeCl3/g of mouse]) 2 h before challenge, and virulence was determined
after i.p. injection according to methods described previously (35). For
both eels and mice, a total of six animals were used per control, strain, and
dose and were maintained in independent cages or tanks (13, 35). Animal
mortality was recorded for 1 week and was considered only if the inocu-
lated bacterium was reisolated in pure culture from the moribund animal.
Virulence (50% lethal dose [LD50]) was calculated according to the
method of Reed and Muench (46) and was expressed as CFU/g (i.p. injec-
tion) or ml of infective bath (immersion challenge).
(iii) Colonization. A total of 24 eels per strain were bath infected
according to methods described previously (13), with a bacterial dose
corresponding to the LD50 of the wild-type strain, and 6 were immersed
under the same conditions in PBS-1 (control). Twelve live eels were then
randomly sampled at 0, 9, 24, and 72 h, at a ratio of 3 eels per sampling
point (47, 48). Samples for bacterial counting on TSA-1 were taken from
blood, head kidney, liver, spleen, and gills according to methods described
previously (48), and bacterial counts were expressed as CFU/ml (blood)
or CFU/g.
RNA isolation and quantitative reverse transcription-PCR (qRT-
PCR). Total RNA from bacterial cultures in the mid-log phase or from
infected eel tissues was prepared with Tri reagent (Sigma). RNA extrac-
tions were subjected twice to DNase treatment with Turbo DNase (Am-
bion), extending the reaction time up to 45 min at 37°C. To clean the
Turbo DNase reaction mixtures and concentrate RNA, samples were sub-
Iron Uptake and Virulence in Vibrio vulniﬁcus
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jected to a cleaning step by using the RNeasy MinEute Cleanup kit (Qia-
gen). RNA was quantified with a Biophotometer (Eppendorf) and used to
obtain cDNA by using Moloney murine leukemia virus (M-MLV) reverse
transcriptase (Invitrogen). For each reaction, 1 g of total purified RNA
was used. Quantification of cDNA by quantitative PCR (qPCR) was per-
formed with Power SYBR green PCR Master Mix (Applied Biosystems)
with a StepOne Plus RT-PCR system (Applied Biosystems). The threshold
cycle (CT) values were determined with StepOne software V2.0 (Applied
Biosystems), to establish the relative RNA levels of the tested genes. Prim-
ers specific to recA (recA-F/recA-R), hutR (hutR-qF/hutR-qR), hupA
(hupA-qF/hupA-qR), and vuuA (vuuA-qF/vuuA-qR) were used to am-
plify DNA fragments of about 60 to 70 bp (Table 2). DNA denaturing was
conducted from 60°C to 95°C to obtain the melting curve for determining
the PCR amplification specificity. For each tested gene, three independent
bacterial cultures were subjected to RNA extraction and cDNA isolation,
and for each one, three measurements of cDNA were performed. The
housekeeping gene recA was used as a standard, and the fold induction
(2CT) for each gene was calculated according to methods described
previously (49).
DNA isolation and sequencing. Genomic DNA was extracted, ac-
cording to the miniprep protocol for genomic DNA extraction (50), from
a selection of V. vulnificus strains representative of the genetic and phe-
notypic variability of the species (Table 1). Primers were designed from
the genome ofV. vulnificusYJ016 by using vector NTI 9.1.0 (Table 2). PCR
was performed in a 20-l reaction volume that contained 0.2M forward
and reverse primers, 1.5 U of Taq DNA polymerase (GoTaq, 5 U/l;
Promega), 4 l of 5	 Taq reaction buffer (GoTaq Green; Promega), 0.5
mM MgCl2, 0.1 mM deoxynucleoside triphosphate (dNTP) mix (Pro-
mega), and 2 l of DNA. PCR was performed in a Techne thermocycler
(TC-412). The reaction started with 10 min of denaturation at 94°C,
which was followed by 35 cycles of 40 s of denaturation at 94°C, 45 s of
annealing at 50°C to 54°C, and 45 s of extension at 72°C. An additional
extension step at 72°C for 10 min completed the reaction. Amplicons were
examined by agarose gel electrophoresis (1%) and ethidium bromide
staining. PCR products of the predicted size were purified and sequenced
in an ABI 3730 sequencer (Applied Biosystems).
Phylogenetic analysis. The evolutionary scenario of vuuA and hupA
was evaluated from the whole sequence of each gene and was compared
with an MLSA reconstruction (51) from the partial sequences (254 nucle-
otides [nt] by gene) of four virulence-associated genes (vvha, rtxA1, wzz,
and pilF) and four housekeeping genes (glp, mdh, pyrC, and pntA) taken
from GenBank (17, 52–56). Phylogenetic trees for each single gene and for
the concatenated MLSA were obtained by using the maximum likelihood
(ML) method with PhyML software (57). The best evolutionary model for
TABLE 2 Primers used in this study
Primer Restriction site Sequence Product size (bp) Utilization
hupA-1 SphI CGGCATGCCAGTAAGAATCCATTAGAGG 1,401 Mutant construction
hupA-2 KpnI CGGGTACCCGTGATTTAACTCAAGCAG Mutant construction
hupA-3 KpnI CGGGTACCATCTTGAGCTTGTACTGG 1,407 Mutant construction
hupA-4 SphI CGGCATGCGTCCTGATGAATAAGATC Mutant construction
vuuA-1 SalI CGGTCGACATTCCTACACTTAGCCGC 1,404 Mutant construction
vuuA-2 KpnI CGGGTACCCTAAAACAGCAACCACGT Mutant construction
vuuA-3 KpnI CGGGTACCCCCCATCACTACCGCAGAC 1,401 Mutant construction
vuuA-4 SacI CGGAGCTCTCCGTGATGATATTGCTAAG Mutant construction
hutR-1 SalI GCGTCGACTATGCCGCCAGTGATGCAAA 1,435 Mutant construction
hutR-2 PstI GCCTGCAGGTTGGCAGCGAGTACCGAC Mutant construction
hutR-3 PstI GCCTGCAGACTTATTCCACAGAGCCGGGG 1,423 Mutant construction
hutR-4 SphI GCGCATGCCCATACATACCTTGCAAAACG Mutant construction
hupA-cF TTAGAAGTTGTATTTCACAC 2,366 Mutant complementation
hupA-cR TTTAACTCCTTTGGTGATC Mutant complementation
vuuA-cF CTAGAAGTTCAACTGCAATG 2,407 Mutant complementation
vuuA-cR AGGCATCTCATGCGGTGAG Mutant complementation
hupA-seq1 GAATGAGACTTAAAAAGCC 1,001 Sequencing
hupA-seq2 CCTGATGCGAAGGAAATGA Sequencing
hupA-seq3 TCATAACGAACACCAGGAG 964 Sequencing
hupA-seq4 CAGCCAGGCGTGTTTGAT Sequencing
hupA-seq5 CATATCCGGATCAACCGTGA 500 Sequencing
hupA-seq6 GGAACGACATAAGAGCCAT Sequencing
vuuA-seq1 CTCTGGTCAACATCAGAGGC 1,122 Sequencing
vuuA-seq2 ATGATCGATACACTAATCCG Sequencing
vuuA-seq3 AACTCTTTACCTTCAGTGG 1,101 Sequencing
vuuA-seq4 CATCCTGAATGCAATCAG Sequencing
hutR seq-1 GGACAGGCGTAAAGGATTGG 1,229 Sequencing
hutR seq-2 GACGCTCAGACGTTCTCGAA Sequencing
hutR seq-3 TGCTGATATGACCAAGGCG 1,231 Sequencing
hutR seq-4 TGCTGTACTTGCTCGACGC Sequencing
recA-F CGCCAAAGGCAGAAATCG 59 qRT-PCR
recA-R ACGAGCTTGAAGACCCATGTG qRT-PCR
hutR-qF CATGGCGGATGTTGAAGATATC 76 qRT-PCR
hutR-qR AACTGCGTTTTTGCTCCGTAA qRT-PCR
hupA-qF AAGCTAGATGCTGCGCCTTT 60 qRT-PCR
hupA-qR CACGGTTGATCCGGATATGC qRT-PCR
vuuA-qF GGACCACGGGAATCCATATG 56 qRT-PCR
vuuA-qR TGCGTTGGCGGGTTTTA qRT-PCR
Pajuelo et al.
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the sequences according to jModelTest (58) and considering the Akaike
information criterion (AIC) (59) was found to be the Tamura 3-parame-
ter model (T92 model) (60) for the vuuA and hupA genes and for the
MLSA-concatenated alignment. The model was applied with a gamma
distribution and invariant sites accounting for heterogeneity in evolution-
ary rates among sites. Support for the groupings derived in these recon-
structions was evaluated by bootstrapping using 1,000 replicates. No out-
groups were used for the analysis of both genes due to the huge
interspecies differences. The congruence among phylogenetic reconstruc-
tions obtained with the different alignments was checked by using Shimo-
daira-Hasegawa (SH) (61) and expected-likelihood weight (ELW) tests as
implemented in TreePuzzle, version 5.2 (62, 63).
Molecular clock estimation for vuuA and hupA. The following equa-
tion was used to roughly determine the age of divergence for each pairwise
comparison: number of synonymous single-nucleotide polymorphisms
(sSNPs)/(number of sSNP sites	mutation rate	number of generations
per year) (64). The sSNPs were selected because they are believed to be
neutral or nearly neutral in terms of selection and therefore allow for a
relatively unbiased estimation of SNP accumulation (64). The number of
potential sSNP sites for each codon was calculated from a lookup table of
codon possibilities and added together to give the number of potential
sSNP sites for all the codons in the sequence. Since the synonymous mu-
tation rate of V. vulnificus is unknown, we selected a value of 1.4	 1010
mutations per base pair per generation based on mutation rate data from
E. coli (65). The generation times in vitro forV. vulnificus biotypes 1, 2, and
3 are 4.0, 2.9, and 2.4 generations h1, respectively (66). However, there
are no data on generation time in the environment. On the basis of the
estimations performed for E. coli (100 to 300 generations/year) (67), Ba-
cillus anthracis (43 generations per year) (68), and Vibrio parahaemolyti-
cus (100 generations per year) (69), we chose a value of 365 generations
per year for V. vulnificus.
Statistical analysis. All the experiments were performed in triplicate,
and significance of the differences was tested by using the unpaired Stu-
dent t test with a P value of
0.05.
Nucleotide sequence accession numbers. Sequences for hupA, vuuA,
and hutR were deposited into GenBank under accession numbers
KC741503, KC741545, and KF056337.
RESULTS
FURTA and siderophore assays. The open reading frames (ORFs)
with significant homology to V. vulnificus Bt1 genes identified by
FURTA are shown in Table S1 in the supplemental material. The
set includes chromosomal genes such as the genes for the recep-
tors HupA (clone DP006) and VuuA (clone DP009) (but not for
the receptor HutR), for vulnibactin and heme transport, and for
vulnibactin biosynthesis as well as a plasmid gene of unknown
function (see Table S1 in the supplemental material). No gene
related to hydroxamate-type siderophore biosynthesis could be
identified, although a cluster of genes for exogenous aerobactin
utilization was found (see Table S1 in the supplemental material).
Accordingly, the strain was positive in the CAS assay, a universal
assay for siderophore detection; positive in the test for phenolates;
and negative in the test for hydroxamates (Table 3).
Isolationandcharacterizationof the single andmultiplemu-
tants. (i) Furbox and sequencing.Clones DP006 and DP009 were
sequenced, and two fur boxes with the sequences GCTAATGAT
AATTACTATC and GCAAAGCATTCTCATTTGC, highly simi-
lar to those identified previously by Litwin and Byrne (28) in hupA
(identical) and by Webster and Litwin (27) in vuuA (18/19), were
identified. In parallel, hupA and vuuA, together with hutR (se-
lected despite not being identified by FURTA), were sequenced in
strain CECT4999 (Table 1), using primers from the genome se-
quence of Bt1 strain YJ016 (Table 2). The hupA, vuuA, and hutR
genes showed 97%, 95%, and 97% similarity values (in amino acid
sequence) with respect to the homologous ones in Bt1 strain
YJ016, respectively.
(ii) Transcription versus iron starvation. A positive fold in-
duction for the three genes was observed in vitro when bacteria were
subjected to the iron-restricted conditions imposed by apo-Tf (Fig.
1A). In the case of genes for Hm receptors, the transcription level of
hupA was significantly higher than that of hutR (Fig. 1A). A positive
fold induction of vuuA and hupA was also detected when fresh
plasma from either humans or eels was added to CM9 (Fig. 1A). This
positive stimulation of gene transcription of vuuA and hupA was
abolished when FeCl3 was added to plasma at concentrations of 20
M and 200 M, respectively, which suggests that transcription of
vuuA is more sensitive to iron concentrations.
(iii) OMPprofiles and siderophore production. According to
data described previously (27, 28), the OMP profiles of hupA
and vuuA strains lack proteins of 77 and 72 kDa, respectively,
which were present in the OMP profiles of the wild-type strain and
the complemented strains (Fig. 2). No difference in protein profile
TABLE 3 Virulence, siderophore production, and growth in serum and with holo-Tf as the sole iron sourcee
Strain
Virulence (LD50)
a
Siderophore production
resultb
Growth in fresh
serum fromc:
Mean growth (mm) with
holo-Tf SDd
Mice
(CFU/mouse)
Eels
Arnow Csàky CAS Humans Eelsi.p. (CFU/eel) Bath (CFU/ml)
CECT4999 3.16	 102 2.1	 102 4.4	 106    151.3 141.26 17.3 2.8
vuuA 4.01	 103 1.0	 104 108    5.68 9.55 0
hupA 8.97	 103 1.7	 104 108    4.02 3.23 ND
hutR 3.2	 102 2.0	 102 5	 106    ND ND ND
cvuuA ND 6.2	 102 4.1	 106    80.2 165.5 16.3 2.8
chupA ND 5.7	 102 5.6	 106    178.1 108.6 ND
vuuA hupA 107 7.4	 105 108    3.73 4.8 ND
a The LD50 for mice was determined by using the iron-overloaded model (35). The LD50 is expressed as CFU per fish or mouse in the case of i.p. injection and CFU per ml in the
case of bath infection of eels (13).
b Criteria for positive or negative results for each test according to reference 31.
c Ratio between final and initial bacterial counts on TSA-1 plates after 4 h of incubation in fresh serum.
d Diameter of growth halo in mm around Tf discs (soaked in a solution of 1 mM holo-Tf) placed onto CM9A-E plates previously inoculated with 100 l of a culture grown
overnight in CM9.
e ND, not done.
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was apparent when OMP of the hutR strain was compared with
those of the wild-type and the complemented strains (data not
shown). As expected, none of the mutations affected the ability to
produce siderophores (Table 3).
(iv) Utilization of iron from holo-Tf and Hm. The vuuA
strain was unable to use iron from holo-Tf (Table 3), while the
hupA and hutR strains grew with Hm as the sole iron source
but with different growth patterns (Fig. 3). Thus, thehupA strain
grew significantly less than the wild-type strain and showed a re-
tarded log phase, while the hutR strain grew as efficiently as the
wild-type strain (Fig. 3). A hupA hutR double mutant was con-
structed as described in Materials and Methods. The double mu-
tant was unable to grow with Hm as the only iron source (Fig. 3).
In all cases, the complemented strains presented the wild-type
phenotype (Table 3 and Fig. 3).
(v) Virulence for mice and eels. The hupA and vuuA single
FIG 1 Effect of iron starvation on transcription of hutR, hupA, and vuuA. (A) Transcription of the hutR, hupA, and vuuA genes was measured by qRT-PCR in
the mid-log phase of growth for CM9 (control), iron-free CM9 (CM9 plus 100 M EDDA) supplemented with different iron sources (1% eel erythrocytes
[CM9-EE], 10 M bovine hemin [CM9-Hm-10], or 10 M bovine hemoglobin [CM9-Hb-10]), and iron-free CM9 (CM9 plus plasma [CM9-EP or CM9-HP]
supplemented with 20 or 200M FeCl3 [CM9-EP-Fe20, CM9-EP-Fe200, CM9-HP-Fe20, or CM9-HP-Fe200]). (B) Time course analysis of hupA (i and iii) and
vuuA (ii and iv) transcription in CM9-Tf (i and ii) and CM9-EP (iii and iv) measured by qRT-PCR (continuous line) versus bacterial growth (dashed line).
Asterisks denote significant differences (P
 0.05) compared with the control conditions (CM9).
Pajuelo et al.
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mutants showed a similar increase in the LD50 values in both an-
imal models (between 1 and 2 log units) (Table 3). Surprisingly,
both mutants were completely avirulent when they were admin-
istered to eels through water, which is the natural route of vibriosis
transmission (Table 3). In contrast, the hutR single mutant was as
virulent as the wild-type strain in both animal models (Table 3),
and as a consequence, it was excluded from subsequent experi-
ments.
A hupA vuuA double mutant was found to be completely avir-
ulent for mice and almost avirulent for i.p. injected eels (Table 3).
As expected, the double mutant was avirulent for eels infected
through water. Finally, the complemented strains exhibited the
wild-type level of virulence for eels and mice (Table 3).
Colonization and invasion assays. (i) In vivo assays. To dis-
cover whether vuuA and/or hupA plays a role in host colonization
and/or invasion (spreading and colonization of the internal or-
gans), the well-established eel model was selected (48). The two
single mutants were able to colonize the gills and establish a pop-
ulation with a size similar to that of the wild-type strain (Fig. 4A).
From this location, the single mutants spread to the internal or-
gans, where they survived
72 h postchallenge (Fig. 4A). No sig-
nificant difference in the degree of colonization of internal organs
was detected between thehupA andvuuA strains, although the
hupA strain spread faster in blood. Finally, the double mutant
was able to colonize the gills but failed to spread to internal organs
(data not shown).
In parallel, samples of internal and external organs from eels
infected with the wild-type strain were processed to determine
whether both genes were induced during the infection process. As
observed in Fig. 4B, overexpression of genes was not induced in
gills at any of the assayed times but was significantly induced in
blood at 9 h and in all the internal organs sampled at 24 h (except
for vuuA, which was not induced in head kidney) but became
undetectable at 72 h postchallenge.
(ii) In vitro assay. Single and double mutants were able to
survive and grow in fresh eel plasma and human plasma although
at significantly lower rates than the wild-type and the comple-
mented strains (Table 3 and Fig. 5). Interestingly, the growth of
each strain did not vary significantly with regard to the tested
condition (blood versus plasma or human versus eel) (Fig. 5), and
therefore, EP was the condition selected to demonstrate that the
reduction in the growth rate was due to the bacteriostatic effect of
Tf and not to the bacteriolytic action of complement. As expected,
significant differences in bacterial growth between each mutant
and the wild-type strain were still found after complement inacti-
vation but not after iron supplementation (Fig. 5). Finally, the
complemented strains showed a growth rate similar to that of the
wild-type strain under all assayed conditions (Fig. 5).
To relate growth rate and gene expression, we studied the fold
induction of hupA and vuuA versus the growth of the wild-type
strain under iron-restriction conditions (apo-Tf for fresh EP). As
shown in Fig. 1B, transcription of both genes was induced just
before the early log phase and was maintained for 10 h, indicating
that both genes are expressed before the utilization of HupA and
VuuA as iron receptors for active growth.
Phylogeny of vuuA and hupA. The vuuA and hupA genes were
sequenced for a collection of V. vulnificus strains from clinical and
environmental sources belonging to the three biotypes and the
three previously defined phylogroups (17) (GenBank accession
numbers KC741503 to KC741545 and KF056337).The phyloge-
netic reconstruction using the maximum likelihood (ML) method
showed that the vuuA gene has two main variants (Fig. 6): vuuA
variant I [vuuA(I)] is present in 26 of the 29 studied strains, in-
cluding sequenced strain YJ016 (of Bt1 and of clinical origin) and
all the Bt2 and Bt3 strains, and vuuA(II) is present in a few envi-
ronmental and clinical Bt1 strains, including sequenced strain
CMCP6 (54). The intervariant identity in both DNA and protein
sequences is around 80 to 85%, while the intravariant identity is
between 89.7 and 90.3% for vuuA(I) and between 97.7 and 98.1%
for vuuA(II). The hupA gene also presents two main variants (Fig.
6): hupA(I) was found in all strains from diseased fish and clinical
cases associated with fish manipulation; hupA(II) also has two
subforms, one defective because it lacks a fragment of 2,035 nt in
the 5= portion of the gene [hupA(IIa)] and the other complete
[hupA(IIb)] (Fig. 6). The intervariant identity in both DNA and
protein sequences was between 91.6 and 95.6%, while the intra-
variant identities were from 96.1 to 95.9% for hupA(I) and 95 to
95.1% for hupA(II), being 100% for hupA(IIa) and between 95
and 95.1% for hupA(IIb). The sequences of both genes were com-
pared to identify the regions where the mutations accumulated. As
shown in Tables S2 and S3 in the supplemental material, varia-
tions were detected throughout the protein. Meanwhile, vuuA
presented changes in 156 amino acids (63.5% amino acids of dif-
ferent families and 36.5% amino acids of the same family), while
hupA showed variations in 41 amino acids (68.3% amino acids of
different families and 31.7% amino acids of the same family).
FIG 2 OMP profiles obtained by SDS-PAGE. Lane 1, CECT4999 in CM9-Fe;
lane 2, CECT4999 in CM9-Tf; lane 3, the vuuA strain in CM9-Tf; lane 4, the
cvuuA strain in CM9-Tf; lane 5, thehupA strain in CM9-Tf; lane 6, the chupA
strain in CM9-Tf. Arrows indicate bands of 72 and 77 kDa.
FIG 3 Growth of V. vulnificus strains with hemin as the sole iron source
(CM9-Hm-0.1). Cultures of CECT4999, the hupA and hupR single mu-
tants, thehupAhupRdouble mutant, and the chupA strain grown overnight
were used to inoculate (1:100, vol/vol) CM9-Hm-0.1 (0.1M hemin plus 100
M EDDA), and the OD600 was measured at 1-h intervals for 10 h, with a final
reading at 24 h postinoculation.
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The phylogenetic trees for each gene were compared with that
obtained by MLSA from the selected housekeeping and virulence-
related genes to discover whether their phylogenetic histories were
congruent with one another. Figure 6 shows the MLSA tree for the
species obtained from the concatenated selected genes (house-
keeping [glp, mdh, pyrC, and pntA] and virulence related [vvha,
rtxA1, wzz, and pilF]), together with the trees obtained for vuuA
and hupA. The results of the Shimodaira-Hasegawa (SH) and ex-
pected-likelihood weight (ELW) tests are summarized in Table 4.
All the comparisons were highly significant for both tests, which
indicates that the phylogenetic reconstructions obtained from
each single gene (vuuA or hupA) are congruent with one another
and with the species tree, thus providing statistical support for
similar evolutionary rates. In other words, the evolutionary his-
tory of vuuA and hupA does not differ significantly from that of
the species inferred from the MLSA of the selected housekeeping
FIG 4 Eel colonization and invasion assays and in vivo gene overexpression. (A) Eels were bath infected with the wild-type strain (CECT4999) or with each one
of the single mutants (hupA or vuuA) at a dose of 106 CFU/ml for 1 h. The degree of bacterial colonization of external (gills) and internal (blood, liver, head
kidney, and spleen) organs was then measured as bacterial counts (CFU per g or ml) at 0, 9, 24, and 72 h postchallenge. Asterisks indicate significant differences
in bacteria recovered from mutant strain- and wild-type strain-infected eels (P
 0.05). (B) Eels were bath infected with the wild-type strain (CECT4999) at a dose
of 106 CFU/ml for 1 h, and gene expression levels of vuuA and hupAwere determined in external (gills) and internal (blood, liver, head kidney, and spleen) organs
by qRT-PCR at 0, 9, 24, and 72 h postchallenge. Asterisks indicate significant induction of each gene with respect to the expression level in CM9 (P
 0.05).
Pajuelo et al.
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and virulence-related genes, all of them belonging to the core
genes.
We also estimated the time of divergence by using sSNPs (64).
The number of sSNPs for the hupA gene ranged from 0 to 86, with
an average of 22 sSNPs/strain. In the case of vuuA type I, the
average number of sSNPs was 49/strain (ranging from 0 to 119),
and for type II, the average number was 21/strain (ranging from 16
to 26). The potential numbers of sSNP sites were 2,047 for hupA
and 2,018 and 1,962 for vuuA types I and II, respectively. These
numbers were used to calculate the molecular clock, the results of
which are shown in Tables 5 to 7. According to the model used,
based on E. coli (365 generations per year and a mutation rate of
5.4 	 1010), Bt1 strains diverged from each other an average of
55,000 years ago, regardless of the considered gene, whereas
strains within the other groups diverged from 0 years ago (Bt3) to
20,000 years ago (Bt2) in the case of hupA and from 0 years ago
(Bt3) to 73,000 years ago (Bt2) in the case of vuuA.
DISCUSSION
The present work focused on the host-nonspecific iron acquisi-
tion systems, believed to be chromosomal, that the zoonotic sero-
var of V. vulnificus employs to infect both humans and fish. To do
so, mice and eels were chosen as animal models to test the role that
these mechanisms play in virulence. Previous studies on the iron
uptake mechanisms of V. vulnificus Bt2, and in particular the zoo-
notic variant, suggest that it is able to produce phenolate- and
hydroxamate-type siderophores and to use Hm as the sole iron
source (31, 32). On the basis of siderophore production by Bt1
strains, it was hypothesized that Bt2 strains produce vulnibactin
and a new hydroxamate-type siderophore (31). The genes for bio-
synthesis and uptake of vulnibactin were identified by FURTA,
but no gene related to hydroxamate production was detected. This
finding was further confirmed by performing specific tests for
siderophore detection, which were positive only for phenolate
production. Thus, the selected strain of the zoonotic serovar pro-
duces only vulnibactin, demonstrating that there are differences
in siderophore production among strains of the same clonal com-
plex. Additional identified genes were those related to exogenous
aerobactin uptake, previously identified in Bt1 of the species (70),
as well as those related to Hm uptake, which would constitute the
genetic basis for this previously reported ability (32).
The hypothesis of the present study is that the iron uptake
systems from vulnibactin and Hm are host-nonspecific virulence
factors. The selected genes (vuuA, hupA, and hutR) were se-
quenced, and the corresponding proteins showed a similarity
value of 95% with regard to the clinical Bt1 strain used as a
reference. The single mutants and corresponding complemented
strains were obtained by allelic exchange and were phenotypically
evaluated in terms of siderophore production, OMP profiles, and
growth in the presence of holo-Tf or Hm as the sole iron source. In
general terms, the phenotype obtained was the expected one.
Thus, vulnibactin production was not affected by any of the three
mutations, the OMP profiles from vuuA and hupA strains
lacked the corresponding predicted band, and the vuuA strain
FIG 5 Growth in plasma and blood. Bacterial growth of V. vulnificus strains in plasma and blood is presented as an increase of CFU/ml, expressed as log10 units,
after 4 h of incubation. (A) Fresh eel plasma (EP); (B) EP plus 200M FeCl3; (C) heat-inactivated EP; (D) heat-inactivated EP plus 200MFeCl3; (E) eel blood;
(F) human plasma. Asterisks indicate significant differences in growth between the mutant and wild-type strains (P
 0.05).
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FIG 6 Phylogenetic trees. The maximum likelihood tree was derived from the vuuA and hupA genes and MLSA by the T92 model using a discrete Gamma
distribution plus assuming that a certain fraction of sites are evolutionarily invariable. Bootstrap support values of 70% are indicated in the corresponding
nodes.
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was unable to grow in the presence of holo-Tf as the sole iron
source. With respect to hutR, we did not detect differences in
OMP profiles between the mutant and wild-type strains, which
correlates with the results obtained by Datta and Crosa (30), who
suggested that HutR is a minority protein in the outer membrane.
Regarding iron uptake from Hm, we found that hupA is the gene
mainly involved in this system, since its disruption significantly
diminished the ability to grow with Hm as the sole iron source.
However, hutR is also needed to completely abolish growth ability
in vitro. This result is also compatible with those obtained by Datta
and Crosa (30), who suggested that hutR plays a secondary role in
the use of Hm by V. vulnificus Bt1. In parallel, we confirmed that
the three genes were induced under iron restriction conditions
and that hupA was expressed at a significantly higher level than
hutR, a result again in concordance with the hypothesis that hutR
is secondary in Hm uptake. The finding that vuuA and hupA were
maximally induced in the log phase of growth suggests that they
are probably involved in active growth both in vivo and in vitro.
Finally, the complemented strains showed the phenotype of the
wild-type strain, demonstrating that in each case, the mutation
affected only the target gene(s).
The results obtained in the virulence assays support the hy-
pothesis on the role of hupA and vuuA as host-nonspecific viru-
lence genes. Thus, in single-gene (hupA or vuuA) knockout mu-
tants, virulence was attenuated by 1 to 2 logs for both i.p. injected
eels and mice, while virulence was completely abolished for eels
when bacteria were administered by water, the natural route for
vibriosis transmission. In contrast, hutR was found not to be a
virulence gene since its mutation did not affect the lethal dose for
either animal model. This result is compatible with those obtained
in vitro and also supports the hypothesis posed by Datta and Crosa
(30). Interestingly, the double-gene (hupA and vuuA) knockout
mutant was completely avirulent for mice and almost avirulent for
eels, both inoculated by the i.p. route, suggesting that iron acqui-
sition by either ferric vulnibactin or heme uptake is essential for
the zoonotic serovar to cause sepsis in both mice and eels. The fact
that virulence of the double mutant (vuuA and hupA) was not
completely abolished for eels suggests that the zoonotic strain may
employ a third iron acquisition system, which is probably host
specific. In fact, one of the genes identified by FURTA was a plas-
mid gene, vep20, previously annotated as a putative receptor for Tf
(16) on the basis of its low similarity with a gene encoding a pu-
tative Tf receptor in Histophilus somni, one of the key bacterial
pathogens involved in the multifactorial etiology of the bovine
respiratory disease complex (71). A BLASTP search revealed that
the highest homology for this protein is in a series of putative
Tf/Hb-binding proteins in various human and fish pathogens
(Vibrio harveyi, Photobacterium damselae, Neisseria meningitidis,
and Bordetella sp.). pVvBt2 contains a system that enables the
bacterium to survive the innate immune system of teleosts (18;
our unpublished results). One of the genes involved, namely,
vep07, encodes an outer membrane lipoprotein that confers resis-
tance to fish serum activated by the alternative route (C.-T. Lee, D.
Pajuelo, C. Amaro, and L. Hor, unpublished data). Our unpub-
lished data suggest that another gene in pVvBt2, vep20, probably
encodes a host-specific receptor for Tf involved in the phenotype
of resistance to the innate immune system of teleosts. Further
studies are under way to test this hypothesis.
On the basis that vuuA and hupA are virulence genes, the next
step was to discover their specific roles in human and fish vibriosis.
To this end, we performed a series of in vivo and in vitro experi-
ments under the hypothesis that this pathogen needs both genes to
grow in host blood and internal organs and to achieve the popu-
TABLE 4 Summary of Shimodaira-Hasegawa and expected-likelihood
weights for the MLSA sequences and vuuA and hupA genes
Alignment Topology lnLa
Probability valueb
SH test ELW test
MLSA MLSA 7,732.85 1.000 1.000
vuuA 6,246.04 1.000 0.0056
hupA 7,757.89 1.000 0.9589
vuuA vuuA 4,970.60 1.000 0.6663
MLSA 4,347.71 1.000 0.1373
hupA 4,539.55 1.000 0.4489
hupA hupA 4,553.87 1.000 0.0289
vuuA 4,842.49 1.000 1.000
MLSA 4,717.26 1.000 0.9205
a Each alignment was used to evaluate the log likelihood (lnL) of the ML tree obtained
with each of the three data sets.
b The probability values for each topology and test are shown. All the values were in the
0.95 confidence test.
TABLE 5 Average time of divergence for the hupA gene based on sSNP
analysis, taking 365 generations per year and a mutation rate of 5.4	
1010
Biotype
Avg time of divergence (yr) for hupA
Bt1 Bt2-SerE Bt2-SerI Bt2-SerA Bt3
Bt1 55,295.0 63,173.2 61,476.6 61,786.4 74,710.2
Bt2-SerE 63,173.2 1,321.9 19,828.3 6,237.7 29,329.4
Bt2-SerI 61,476.6 19,828.3 20,447.9 19,518.5 29,432.6
Bt2-SerA 61,786.4 6,237.7 19,518.5 8,303.1 26,768.2
Bt3 74,710.2 29,329.4 29,432.6 26,768.2 0.0
TABLE 6 Average time of divergence for vuuA type I based on sSNP
analysis, taking 365 generations per year and a mutation rate of 5.4	
1010
Biotype
Avg time of divergence (yr) for vuuA type I
Bt1 SerE SerI SerA Bt3
Bt1 56,847.9 85,458.0 65,612.5 89,392.2 93,163.4
Bt2-SerE 85,458.0 13,744.1 73,067.7 9,134.8 31,007.9
Bt2-SerI 65,612.5 73,067.7 42,950.2 79,195.9 7,416.6
Bt2-SerA 89,392.2 9,134.8 79,195.9 4,022.6 21,873.2
Bt3 93,163.4 31,007.9 74,167.6 21,873.2 0.0
TABLE 7 Average time of divergence for vuuA type II based on sSNP
analysis, taking 365 generations per year and a mutation rate of 5.4	
1010
Straina
Avg time of divergence (yr) for vuuA type II
CMCP6 CECT4608 E64
CMCP6 0 20,113.2 27,655.7
CECT4608 20,113.2 0 32,684.0
E64 27,655.7 32,684.0 0
a All strains are of biotype 1.
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lation size that triggers host death by sepsis. First, both genes were
induced in eels after bath infection, which demonstrated that both
genes are needed in vivo. The induction level of the genes was not
apparently related to the bacterial numbers recovered on the
plates. In fact, we were able to detect a positive induction of vuuA
when no bacterium was recovered on the plates. This apparent
contradiction is explained because vibrios could be in a VNC (vi-
able-but-not-culturable) state, and as a consequence, the obtained
counts underestimate the in vivo bacterial population size. In any
case, the genes were induced only in internal organs (blood,
spleen, and liver) and from 9 h (blood) to 24 h (blood, spleen, and
liver) postinfection, which suggests that VuuA and HupA are used
in vivo during the first 24 h of infection. After this time, cellular
destruction caused by the pathogen would release iron from cel-
lular storage depots that could be used for bacterial growth (48).
This result is also compatible with a hypothesis reported previ-
ously (47), which suggests that the bacterium needs a minimum of
24 h to spread from gills to the internal organs and achieve the
population size that triggers death by sepsis. We then analyzed the
effect of single mutations in vuuA or hupA and that of the double
mutation of both genes on surface and internal colonization of
eels. We found that all the mutant strains, single and double, were
able to colonize the gills as efficiently as the wild-type strain. How-
ever, each of the single mutants was deficient in internal coloniza-
tion. In fact, the single mutants grew significantly less than the
wild-type strain in each organ and were completely eliminated
from internal organs at 72 h postinfection. This result explains
why they were not virulent by bath challenge and suggests that
bacterial growth inside the body is needed by V. vulnificus to over-
come immune defenses. In addition, the double mutant strain
completely lost the ability to spread from the gills to the internal
organs, confirming the importance of iron acquisition by either
system for colonization and invasion. Likewise, either one gene or
the other was needed for efficient growth in human and eel blood
and serum. In fact, both genes were induced in fresh serum from
both humans and eels, which correlates with the results obtained
in vivo and supports the hypothesis on the role played by both iron
uptake systems in the ability of this zoonotic serovar to grow in
blood and cause death by sepsis.
Our next step was to analyze the phylogeny of vuuA and hupA
and compare it with that of the species to discover whether both
genes are part of the accessory genetic elements or part of the core
genes. Interestingly, the phylogenetic trees for each gene were con-
gruent with each other and with the species constructed from the
four housekeeping and four virulence-related genes. This result
strongly suggests that vuuA and hupA are part of the core genes of
the species and have not been acquired through horizontal gene
transfer, as occurs in other pathogenic bacterial species (72). This
finding also suggests that both genes probably play a role not only
in virulence but also in survival outside the hosts of vibrios. Ac-
cordingly, we found two main polymorphic variants for both
genes without an apparent relationship with biotype or origin
(clinical versus environmental) of the isolate. However, a deeper
study of the origin of the isolates provided evidence of some kind
of relationship between receptor variant and environment. Thus,
for hupA, all the strains that produced hupA(I) came from fish
farming-related environments (diseased fish, tank water, healthy
fish, and humans infected through fish handling), which suggests
that hupA could have diverged as a consequence of better adapta-
tion to Hm-containing fish proteins. On the other hand, in vuuA,
this adaption to the environment was evident mainly for the zoo-
notic strains. In this case, the theoretical divergence time for the
gene was much longer than that expected for a clonal complex.
The most plausible explanation would be that the environment
acts as a strong selective force because the main source of variation
for this clonal complex is the multiplicity of environments from
which the strains were isolated (water, healthy fish, diseased fish,
human expectoration, human wound, and human sepsis). The
adaptation to the environment of a siderophore receptor could be
a consequence of changes in the siderophores, produced by mu-
tations in the biosynthetic genes, due to the competence by iron in
the natural environments of the bacteria. The same hypothesis was
proposed to explain the variation in receptors for pyoverdin in
Pseudomonas spp. (73). Another interesting observation provided
by the phylogenetic study was that some Bt1 strains from clinical
and environmental sources presented a truncated form of the
hupA gene. Interestingly, these strains possess a whole hutR gene,
which suggests that they could use this second receptor to take up
iron from heme proteins. This finding provides a biological expla-
nation for the presence of a second gene for the heme receptor in
the genome of the species.
In conclusion, vuuA and hupA are host-nonspecific virulence
genes involved in the colonization and invasion of internal organs
by enabling the bacterium to grow under the iron restriction con-
ditions imposed by mammal and teleost hosts. This work demon-
strates that iron uptake is essential to cause vibriosis in mice and
suggests that probably a third host-specific system could also be
involved in virulence for teleosts, a hypothesis which will have to
be corroborated in further studies. The phylogenetic study also
suggests that both genes are part of the core genes of the species V.
vulnificus and are subjected to variations, probably due to envi-
ronmental adaptations. Finally, hutR encodes a secondary heme
receptor that is not relevant to virulence, although it could be used
by the strains with a truncated form of hupA, like those which we
have found in this study.
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